D

Dynamix Corporation (ETHM)

NGM – Real Time Price. Currency in USD

10.47

0.00 (0.00%)

At close: Mar 27, 2026, 4:00 PM EDT

10.47

0.00 (0.00%)

After-hours: Mar 27, 2026, 4:10 PM EDT

Get all premium features to the best stock analysis tool

Finranks

Company

About us

Contact us

[email protected]

Dynamix Corporation (ETHM)

NGM – Real Time Price. Currency in USD

10.47

0.00 (0.00%)

At close: Mar 27, 2026, 4:00 PM EDT

10.47

0.00 (0.00%)

After-hours: Mar 27, 2026, 4:10 PM EDT

31.10.2025

Spherix Global Insights Launches Market Dynamix™: PD-1 Inhibition in Solid Tumors, Delivering a Comprehensive Assessment of Biosimilar and Subcutaneous PD-1 Market Dynamics Across Key Oncology Indications

EXTON, PA, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Spherix Global Insights has announced the launch of its latest Market Dynamix™ service, PD-1 Inhibition in Solid Tumors (US) 2025, providing an in-depth analysis and advisory services for the evolving immuno-oncology landscape as the next wave of PD-1 biosimilars and subcutaneous (SC) formulations rapidly approach market entry.

Videos

No Data

There is no data to display

Press releases

31.10.2025

Spherix Global Insights Launches Market Dynamix™: PD-1 Inhibition in Solid Tumors, Delivering a Comprehensive Assessment of Biosimilar and Subcutaneous PD-1 Market Dynamics Across Key Oncology Indications

EXTON, PA, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Spherix Global Insights has announced the launch of its latest Market Dynamix™ service, PD-1 Inhibition in Solid Tumors (US) 2025, providing an in-depth analysis and advisory services for the evolving immuno-oncology landscape as the next wave of PD-1 biosimilars and subcutaneous (SC) formulations rapidly approach market entry.

Dynamix Corporation (ETHM)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Dynamix Corporation (ETHM)

Spherix Global Insights Launches Market Dynamix™: PD-1 Inhibition in Solid Tumors, Delivering a Comprehensive Assessment of Biosimilar and Subcutaneous PD-1 Market Dynamics Across Key Oncology Indications

Videos

No Data

Press releases

Spherix Global Insights Launches Market Dynamix™: PD-1 Inhibition in Solid Tumors, Delivering a Comprehensive Assessment of Biosimilar and Subcutaneous PD-1 Market Dynamics Across Key Oncology Indications